Abstract | AIMS: METHODS: A total of 47 SACC were assessed histochemically for paxillin expression. Paxillin immunoreactivity was compared with histological type, clinical stage and distant metastasis. RESULTS:
Paxillin expression was identified in 57.45% of SACC as cytoplasmic staining and the expression was correlated with distant metastasis and clinical stage (P < 0.05), but not with histological type. CONCLUSIONS: Our observations indicate that paxillin expression is upregulated in SACC. High expression of paxillin was correlated with a more advanced stage and metastasis in SACC, suggesting that paxillin is a disease marker in advanced SACC and SACC with distant metastasis, and, consequently, may have value as a therapeutic target for SACC.
|
Authors | Jinna Shi, Shan Wang, Eryang Zhao, Lei Shi, Xin Xu, Ming Fang |
Journal | Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
(J Oral Pathol Med)
Vol. 39
Issue 7
Pg. 548-51
(Aug 01 2010)
ISSN: 1600-0714 [Electronic] Denmark |
PMID | 20136697
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Coloring Agents
- PXN protein, human
- Paxillin
|
Topics |
- Adult
- Aged
- Carcinoma, Adenoid Cystic
(pathology, secondary)
- Coloring Agents
- Cytoplasm
(ultrastructure)
- Extracellular Space
- Female
- Histocytochemistry
- Humans
- Male
- Middle Aged
- Neoplasm Invasiveness
- Neoplasm Staging
- Parotid Neoplasms
(pathology)
- Paxillin
(analysis)
- Salivary Gland Neoplasms
(pathology)
- Salivary Glands, Minor
(pathology)
- Submandibular Gland Neoplasms
(pathology)
- Young Adult
|